Obermeyer Wealth Partners Has $26.34 Million Stock Position in CME Group Inc. (NASDAQ:CME)

Obermeyer Wealth Partners decreased its position in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 1.1% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 113,399 shares of the financial services provider's stock after selling 1,260 shares during the quarter. CME Group comprises approximately 1.4% of Obermeyer Wealth Partners' investment portfolio, making the stock its 28th largest position. Obermeyer Wealth Partners' holdings in CME Group were worth $26,335,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. New Age Alpha Advisors LLC increased its holdings in CME Group by 50.0% during the fourth quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider's stock valued at $30,000 after buying an additional 43 shares during the period. Avidian Wealth Enterprises LLC raised its holdings in CME Group by 2.6% in the fourth quarter. Avidian Wealth Enterprises LLC now owns 1,769 shares of the financial services provider's stock worth $411,000 after purchasing an additional 45 shares in the last quarter. TFC Financial Management Inc. lifted its position in shares of CME Group by 8.4% during the fourth quarter. TFC Financial Management Inc. now owns 592 shares of the financial services provider's stock valued at $137,000 after buying an additional 46 shares during the last quarter. Waldron Private Wealth LLC grew its position in shares of CME Group by 2.0% in the 4th quarter. Waldron Private Wealth LLC now owns 2,362 shares of the financial services provider's stock worth $549,000 after buying an additional 47 shares during the last quarter. Finally, Venturi Wealth Management LLC lifted its position in CME Group by 12.1% during the fourth quarter. Venturi Wealth Management LLC now owns 437 shares of the financial services provider's stock valued at $101,000 after acquiring an additional 47 shares during the last quarter. 87.75% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on CME shares. Royal Bank of Canada reaffirmed a "sector perform" rating and set a $269.00 price target on shares of CME Group in a research report on Thursday, April 3rd. Keefe, Bruyette & Woods increased their price target on CME Group from $265.00 to $273.00 and gave the company a "market perform" rating in a research note on Thursday, April 24th. Morgan Stanley upped their price objective on shares of CME Group from $301.00 to $304.00 and gave the company an "overweight" rating in a report on Thursday, April 24th. Erste Group Bank raised shares of CME Group to a "strong-buy" rating in a research report on Monday, March 17th. Finally, Raymond James upgraded shares of CME Group from a "market perform" rating to an "outperform" rating and set a $287.00 price objective for the company in a research note on Monday, March 10th. Three research analysts have rated the stock with a sell rating, seven have issued a hold rating, five have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and a consensus price target of $256.80.

CME Group Price Performance

Shares of NASDAQ CME opened at $270.47 on Tuesday. The company has a market cap of $97.47 billion, a PE ratio of 27.97, a P/E/G ratio of 6.76 and a beta of 0.45. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.01 and a quick ratio of 1.02. CME Group Inc. has a 1-year low of $190.70 and a 1-year high of $286.48. The stock has a fifty day moving average price of $264.79 and a 200 day moving average price of $246.09.

CME Group (NASDAQ:CME - Get Free Report) last posted its quarterly earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share for the quarter, beating analysts' consensus estimates of $2.61 by $0.19. The firm had revenue of $1.64 billion for the quarter, compared to the consensus estimate of $1.56 billion. CME Group had a return on equity of 13.62% and a net margin of 57.52%. The company's revenue for the quarter was up 10.4% compared to the same quarter last year. During the same period in the previous year, the business earned $2.50 earnings per share. Sell-side analysts forecast that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, June 25th. Stockholders of record on Monday, June 9th will be given a dividend of $1.25 per share. The ex-dividend date of this dividend is Monday, June 9th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.85%. CME Group's payout ratio is 50.30%.

Insider Transactions at CME Group

In related news, Director Dennis Suskind sold 1,000 shares of the business's stock in a transaction dated Tuesday, April 29th. The shares were sold at an average price of $271.28, for a total value of $271,280.00. Following the sale, the director now directly owns 2,915 shares in the company, valued at $790,781.20. The trade was a 25.54% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Julie Winkler sold 11,592 shares of CME Group stock in a transaction dated Thursday, February 13th. The stock was sold at an average price of $249.17, for a total transaction of $2,888,378.64. Following the transaction, the insider now owns 21,885 shares of the company's stock, valued at approximately $5,453,085.45. The trade was a 34.63% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 34,726 shares of company stock valued at $8,975,813 in the last quarter. 0.30% of the stock is currently owned by corporate insiders.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.